dc.contributor.author | Turhal, N. | |
dc.contributor.author | Tural, D. | |
dc.contributor.author | Uysal, M. | |
dc.contributor.author | Uskent, N. | |
dc.contributor.author | Demir, N. | |
dc.contributor.author | Sakin, A. | |
dc.contributor.author | Keskin, S. | |
dc.contributor.author | Tunali, D. | |
dc.contributor.author | Turna, Z. | |
dc.contributor.author | Kilickap, S. | |
dc.contributor.author | Ozturk, A. | |
dc.contributor.author | Karadurmus, N. | |
dc.contributor.author | Korkmaz, T. | |
dc.contributor.author | Yumuk, P. | |
dc.contributor.author | Okutur, S. | |
dc.contributor.author | Meydan, N. | |
dc.contributor.author | Unal, O. | |
dc.contributor.author | Seker, M. | |
dc.contributor.author | Cabuk, D. | |
dc.contributor.author | Olmez, O. | |
dc.contributor.author | Kucukoner, M. | |
dc.contributor.author | Uluc, B. Oyan | |
dc.contributor.author | Gursoy, P. | |
dc.contributor.author | Urvay, S. | |
dc.contributor.author | Yetisyigit, T. | |
dc.contributor.author | Tatli, A. | |
dc.contributor.author | Karaca, S. | |
dc.contributor.author | Karaagac, M. | |
dc.contributor.author | Cubukcu, E. | |
dc.contributor.author | Demirci, U. | |
dc.contributor.author | Sendur, M. A. | |
dc.contributor.author | Yasar, H. | |
dc.contributor.author | Eralp, Y. | |
dc.contributor.author | Basal, F. | |
dc.contributor.author | Cicin, I. | |
dc.contributor.author | Paydas, S. | |
dc.contributor.author | Cilbir, E. | |
dc.contributor.author | Sakalar, T. | |
dc.date.accessioned | 2021-03-05T10:40:07Z | |
dc.date.available | 2021-03-05T10:40:07Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Kilickap S., Ozturk A., Karadurmus N., Korkmaz T., Yumuk P., Cicin I., Paydas S., Cilbir E., Sakalar T., Uysal M., et al., "Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey", JOURNAL OF THORACIC ONCOLOGY, cilt.13, 2018 | |
dc.identifier.issn | 1556-0864 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_a459b333-01d7-4dc3-9a9f-4291d0404899 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/109944 | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.subject | SOLUNUM SİSTEMİ | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | ONKOLOJİ | |
dc.subject | Onkoloji | |
dc.subject | İç Hastalıkları | |
dc.subject | Göğüs Hastalıkları ve Allerji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.title | Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF THORACIC ONCOLOGY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 13 | |
dc.identifier.issue | 10 | |
dc.contributor.firstauthorID | 257937 | |